Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.11

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote ()	4/24/1999 4:48:00 PM
From: DLJMT	Read Replies (1) of 52153

Enzon has been down recently but is poised to explode on news expected soon about PEG-Intron A. See enzn.com and in particular just posted message from president enzn.com for current status. Also check out Schering Plough's annual statement about their expectations. This company is in a good cash flow position and IMHO could be trading 100-150/sh in 2-3 yrs. Has 35% institutional ownership last I looked and seems to be solid. I'm long since in the two's and don't understand why this stock doesn't get more attention. It's head and shoulders above the flavors of the month. Lin

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next